Ra Pharma Doubled Their Stocks by Getting a $2.1 Billion Deal

Ra Pharm is a biopharma, and have just acquired a $2.1 billion deal by joining with UBC, a move which has doubled their stocks.

from Newswire.net: Newsroom https://ift.tt/31ebAuW
via IFTTT